Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 18, 2021

SELL
$2.77 - $4.05 $102,490 - $149,850
-37,000 Closed
0 $0
Q2 2021

Jul 20, 2021

SELL
$1.71 - $4.14 $44,460 - $107,639
-26,000 Reduced 41.27%
37,000 $142,000
Q4 2020

Jan 13, 2021

SELL
$0.36 - $0.95 $2,880 - $7,600
-8,000 Reduced 11.27%
63,000 $55,000
Q2 2019

Jul 15, 2019

BUY
$1.81 - $2.45 $39,820 - $53,900
22,000 Added 44.9%
71,000 $145,000
Q4 2018

Jan 29, 2019

BUY
$2.49 - $4.54 $12,450 - $22,700
5,000 Added 11.36%
49,000 $127,000
Q3 2018

Oct 16, 2018

BUY
$3.4 - $4.84 $149,600 - $212,960
44,000 New
44,000 $210,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $363M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.